Back to search results

Opt-IVF for Personalized IVF Treatment

This study is testing a new computer tool called Opt-IVF. This tool helps doctors figure out the best personalized drug dosage for women undergoing In Vitro Fertilization (IVF) to treat infertility. You could be eligible to join if you are an infertile woman between 20 and 50 years old and are planning to have IVF. The study will compare the Opt-IVF tool to the standard way doctors currently decide dosages. Success will be measured by things like the total amount of medication used, the number of eggs retrieved, and the number of mature eggs. The study is currently unclear about its recruitment status.

Study design
This is a randomized clinical trial with two groups, involving more than 100 women. One group will use dosages predicted by the Opt-IVF tool, and the other will receive standard treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcomes are measured two weeks after the start of the cycle or stimulation cycle.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07148999

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

Recruiting
PHASE1Ages 20–50InterventionalTreatment
Urmila DIwekar
~200 participants
Updated 2025-09-29 on ClinicalTrials.gov
What's tested:Opt-IVFControl

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Total Gonadotropin Dosage
Measured over Two weeks after the start of the cycle
+4 more outcomes measured

Conditions

Infertility (IVF Patients)

Explore related trials

Infertility

Where it's being run

2 sites across 1 states
Texas2

Study leadership

  • Paul Magarelli, M.D., Ph.D. · PRINCIPAL_INVESTIGATOR · IVF Academy USA
  • Francesco Arredondo, MD, Ph.D. · STUDY_DIRECTOR · Positivf Fertility

Who to contact

Urmila Diwekar, Ph.D.
[email protected]
6308863047
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

infertile women

What this trial measures

  • Total Gonadotropin DosageTwo weeks after the start of the cycle

    Total Gonadotropin Dosage for the cycle

  • Total Oocytes RetrievedTwo weeks after the start of the stimulation cycle

    Total Oocytes Retrieved

  • M2 OocytesTwo weeks after the start of the stimulation cycle

    Total M2 Oocytes

  • Total Embryos FormedTwo weeks after the start of stimulation cycle

    Total Embryos Formed

  • Grade A embryos/BlastocytesThree weeks after the start of stimulation cycle

    Grade A Day 3 Embryos or Grade A Day 5 Blastocytes